Evidence map›Paper›PMID 20584581›Full record

ArticleInternational journal of radiation oncology, biology, physics2010

Proteomic analysis of radiation-induced changes in rat lung: Modulation by the superoxide dismutase mimetic MnTE-2-PyP(5+).

Vasily A Yakovlev, Christopher S Rabender, Heidi Sankala, Ben Gauter-Fleckenstein, Katharina Fleckenstein, Ines Batinic-Haberle, Isabel Jackson, Zeljko Vujaskovic, Mitchell S Anscher, Ross B Mikkelsen and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Mitigation of radiation-induced lung injury by genistein and EUK-207.International journal of radiation biology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Vasily A YakovlevDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, 23298, USA.
Christopher S Rabender
Heidi Sankala
Ben Gauter-Fleckenstein
Katharina Fleckenstein
Ines Batinic-Haberle
Isabel Jackson
Zeljko Vujaskovic
Mitchell S Anscher
Ross B Mikkelsen
Paul R Graves
Virginia Commonwealth University · USDuke Medical Center · US

Funding

Somatostatin analogues as countermeasures against intestinal radiation toxicityU19AI067798 · NIAID · DUKE UNIVERSITY · PI CHAO, NELSON J. · 2005 to 2024
$82.1M
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53P01CA072955 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI VALERIE, KRISTOFFER CARL · 1998 to 2007
$6.0M
RAD-Induced Nitric Oxide &Cellular RadiosensitivityR01CA090881 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI MIKKELSEN, ROSS B · 2002 to 2012
$2.4M
Mechanism of hypoxia mediated radiation lung injuryR01CA098452 · NCI · DUKE UNIVERSITY · PI VUJASKOVIC, ZELJKO · 2003 to 2006
$1.1M
Training in Radiation Oncology Translational ResearchT32CA113277 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI MIKKELSEN, ROSS B · 2007 to 2011
$997k
NCI NIH HHS P01 CA072955NCI NIH HHS P01 CA72955NCI NIH HHS R01 CA090881NCI NIH HHS R01 CA 098452NCI NIH HHS R01 CA098452NCI NIH HHS R01 CA90881NCI NIH HHS T32 CA113277NIAID NIH HHS U19 AI067798NIAID NIH HHS U19AI067798
6 · The paper itself

Abstract

purposeTo identify temporal changes in protein expression in the irradiated rat lung and generate putative mechanisms underlying the radioprotective effect of the manganese superoxide dismutase mimetic MnTE-2-PyP(5+). METHODS AND MATERIALS: Female Fischer 344 rats were irradiated to the right hemithorax with a single dose of 28 Gy and killed from day 1 to 20 weeks after irradiation. Proteomic profiling was performed to identify proteins that underwent significant changes in abundance. Some irradiated rats were administered MnTE-2-PyP(5+) and changes in protein expression and phosphorylation determined at 6 weeks after irradiation.

resultsRadiation induced a biphasic stress response in the lung, as shown by the induction of heme oxygenase 1 at 1-3 days and at 6-8 weeks after irradiation. At 6-8 weeks after irradiation, the down-regulation of proteins involved in cytoskeletal architecture (filamin A and talin), antioxidant defense (biliverdin reductase and peroxiredoxin II), and cell signaling (β-catenin, annexin II, and Rho-guanosine diphosphate dissociation inhibitor) was observed. Treatment with MnTE-2-PyP(5+) partially prevented the apparent degradation of filamin and talin, reduced the level of cleaved caspases 3 and 9, and promoted Akt phosphorylation as well as β-catenin expression.

conclusionA significant down-regulation of proteins and an increase in protein markers of apoptosis were observed at the onset of lung injury in the irradiated rat lung. Treatment with MnTE-2-PyP(5+), which has been demonstrated to reduce lung injury from radiation, reduced apparent protein degradation and apoptosis indicators, suggesting that preservation of lung structural integrity and prevention of cell loss may underlie the radioprotective effect of this compound.

Indexed as

AnimalsAnnexin A2Apoptosisbeta CateninCaspase 9Contractile ProteinsDown-RegulationFemaleFilaminsGuanine Nucleotide Dissociation InhibitorsHeme Oxygenase-1LungMetalloporphyrinsMicrofilament ProteinsOxidoreductases Acting on CH-CH Group DonorsPeroxiredoxinsAnnexin A2beta Cateninbiliverdin reductaseCaspase 9Contractile ProteinsFilaminsGuanine Nucleotide Dissociation InhibitorsHeme Oxygenase-1manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrinMetalloporphyrinsMicrofilament ProteinsOxidoreductases Acting on CH-CH Group DonorsPeroxiredoxinsProteinsProto-Oncogene Proteins c-aktRadiation-Protective Agentsrho-Specific Guanine Nucleotide Dissociation InhibitorsRNA, MessengerTalin

Identifiers

PMID20584581
PMCPMC2939237
OpenAlexW2016457968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.